Delivery Order SPE2DB22D3401-SPE2DB24FT3TE

Award Date 7/9/24
Potential Completion Date 7/10/24
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The fixed-price delivery order, valued at $2,919.12, was issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML pharmaceutical product. The $1,741.68 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency that provides logistics, acquisition, and technical services to the U.S. Armed Forces. The award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order valued at $2,177.10 for the supply of the pharmaceutical product TRULICITY 3 MG/0.5 ML PEN 0.5ML. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of June 25, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division provides for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) under a Firm Fixed Price Delivery Order contract valued at $3,789.86. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical...
The federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of pharmaceutical products and medical supplies, including the drug TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, to government agencies. The contract has a ceiling value of $1,198.50 and is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical worth up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC), valued at up to $8,920.36. The contract is for the supply of the prescription drug TRULICITY 1.5 MG/0.5 ML PEN 0.5ML to DLA facilities supporting the Department of Defense. This IDC, valued at up to $999,999,999.00 through December 31, 2025, serves as the primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division is for the delivery of the prescription drug TRULICITY 1.5 MG/0.5 ML PEN 0.5ML to the Defense Logistics Agency (DLA). The award, valued at $2,467.38, is a Delivery Order placed under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range...
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA). The award, valued at $53,005.00, is a delivery order placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen to...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Firm Fixed Price Delivery Order valued at $2,933.10. The contract was awarded by the Defense Logistics Agency (DLA) to provide the pharmaceutical product TRULICITY 3 MG/0.5 ML PEN 0.5ML. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA to deliver a comprehensive range of pharmaceutical products and medical supplies...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of pharmaceutical products, specifically the medication TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $3,020.88 and is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical. This single-award IDC serves as the primary vehicle...
  • SPE2DB22D3401
    Indefinite Delivery Contract
  • SPE2DB22D3401-SPE2DB24FT3TE
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the supply of the pharmaceutical product TRULICITY 3 MG/0.5 ML PEN 0.5ML to the Defense Logistics Agency (DLA). The award, valued at $1,741.68, is structured as a Delivery Order under an Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which has a potential total value of up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation.

Generated 10/8/24, 9:22 AM